Stem Cell Therapeutics for Neurodegenerative Conditions
Summary
Neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis are characterised by progressive loss of specific neuronal populations, synaptic dysfunction and debilitating clinical decline. Stem cell therapeutics offer a multifaceted approach to these disorders by replacing lost or damaged neurons, modulating neuroinflammation and delivering neurotrophic support. Mesenchymal stem cells, neural stem cells and induced pluripotent stem cell–derived neural precursors have been investigated in preclinical models for their capacity to migrate to sites of injury, secrete trophic factors and promote endogenous repair. Strategies to enhance cell survival and integration include genetic modification to overexpress neuroprotective molecules, hypoxic preconditioning and three-dimensional culture scaffolds. Advances in non-invasive delivery—such as intranasal administration of cell secretomes—are broadening accessibility while minimising procedural risk. Early-phase clinical studies have demonstrated safety and feasibility, with some reports of modest functional improvement and stabilisation of disease progression. Remaining challenges encompass efficient engraftment, precise control of differentiation, long-term safety and immune compatibility. Continued refinement of cell sourcing, manufacturing standards and delivery methodologies is essential to translate promising preclinical outcomes into robust, scalable therapies that address the global burden of neurodegenerative disease.
Research from Nature Portfolio
Gain of BDNF function in transplanted neural stem cells has emerged as a seminal strategy to enhance therapeutic outcomes in Alzheimer’s models. Neural stem cells engineered to overexpress brain-derived neurotrophic factor displayed improved survival, neuronal differentiation and neurite outgrowth after engraftment. Electrophysiological assessment revealed that graft-derived neurons integrated into host circuitry and contributed to restoration of synaptic function. Behavioural analyses in transgenic mice demonstrated recovery of memory performance. These findings establish ex vivo gene-enhanced neural stem cell transplantation as a foundational proof of concept for combining cell replacement with targeted neurotrophic support.
Stem Cell Therapeutics for Neurodegenerative Conditions publication trend
The graph below shows the total number of articles in stem cell therapeutics for neurodegenerative conditions across all publications each year (not limited to Nature Index journals).
Technical terms
Mesenchymal stem cells (MSCs): Multipotent stromal cells capable of differentiating into mesodermal lineages and modulating immune responses through paracrine signalling.
Induced pluripotent stem cells (iPSCs): Somatic cells reprogrammed to a pluripotent state, enabling generation of diverse cell types including neural progenitors.
Neural stem cells (NSCs): Self-renewing, multipotent cells that can differentiate into neurons, astrocytes and oligodendrocytes.
Secretome: The repertoire of growth factors, cytokines and extracellular vesicles secreted by cells that mediate paracrine effects.
Engraftment: The process by which transplanted cells survive, integrate and function within host tissue.
Neuroinflammation: An inflammatory response within the central nervous system characterised by glial activation and cytokine release.
Trophic factors: Bioactive molecules such as growth factors that support neuronal survival, differentiation and synaptic plasticity.
References
- TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients. Military Medical Research (2024).
- Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer’s disease. Translational Neurodegeneration (2023).
- Human dental pulp stem cells mitigate the neuropathology and cognitive decline via AKT-GSK3β-Nrf2 pathways in Alzheimer’s disease. International Journal of Oral Science (2024).
- Gain of BDNF Function in Engrafted Neural Stem Cells Promotes the Therapeutic Potential for Alzheimer’s Disease. Scientific Reports (2016).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.